https://scholars.lib.ntu.edu.tw/handle/123456789/496091
標題: | Pioglitazone and thyroid cancer risk in Taiwanese patients with type 2 diabetes | 作者: | CHIN-HSIAO TSENG | 公開日期: | 2014 | 出版社: | John Wiley and Sons Inc. | 卷: | 6 | 期: | 5 | 起(迄)頁: | 448-450 | 來源出版物: | Journal of Diabetes | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906251728&doi=10.1111%2f1753-0407.12149&partnerID=40&md5=773138137786083dc2744c5aac18de70 https://scholars.lib.ntu.edu.tw/handle/123456789/496091 |
ISSN: | 1753-0393 | DOI: | 10.1111/1753-0407.12149 | SDG/關鍵字: | acarbose; acetylsalicylic acid; angiotensin receptor antagonist; calcium channel blocking agent; clopidogrel; dipeptidyl carboxypeptidase inhibitor; dipyridamole; fibric acid derivative; hydroxymethylglutaryl coenzyme A reductase inhibitor; insulin; metformin; nonsteroid antiinflammatory agent; pioglitazone; rosiglitazone; sulfonylurea; ticlopidine; 2,4 thiazolidinedione derivative; antidiabetic agent; pioglitazone; adult; aged; article; cancer risk; comorbidity; dose response; female; human; insulin treatment; major clinical study; male; non insulin dependent diabetes mellitus; priority journal; Taiwan; thyroid cancer; treatment duration; Diabetes Mellitus, Type 2; insulin resistance; middle aged; protection; risk assessment; risk factor; Thyroid Neoplasms; time; treatment outcome; Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Protective Factors; Risk Assessment; Risk Factors; Taiwan; Thiazolidinediones; Thyroid Neoplasms; Time Factors; Treatment Outcome |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。